University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Effects of Acute Prucalopride Administration in Healthy Volunteers

Not Applicable

Completed

Conditions: Mood Disorders
Mental Disorder
Molecular Mechanisms of Pharmacological Action
Antidepressive Agents
Depression
Depressive Disorder
Cognition

Interventions: Other: Placebo
Drug: Prucalopride

First Posted Date: 2019-03-05

Last Posted Date: 2019-03-05

Lead Sponsor: University of Oxford

Target Recruit Count: 41

Registration Number: NCT03863366

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial

Phase 2

Completed

Conditions: Small Vessel Cerebrovascular Disease

Interventions: Drug: Placebo
Drug: Cilostazol
Drug: Sildenafil

First Posted Date: 2019-02-26

Last Posted Date: 2023-02-24

Lead Sponsor: University of Oxford

Target Recruit Count: 75

Registration Number: NCT03855332

Locations: 🇬🇧
University of Oxford, Oxford, Oxon, United Kingdom

Type 2 Diabetes: Risk Perceptions and Self-management Behaviour

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Other: Personalized Risk Communication for People with Type 2 Diabetes

First Posted Date: 2019-02-15

Last Posted Date: 2019-02-15

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT03840850

Locations: 🇬🇧
27 Beaumont Street Surgery Practice, Oxford, Oxfordshire, United Kingdom

VAccination in Early and ADvanced Prostate caNCEr

Phase 1

Conditions: Castration-resistant Prostate Cancer
Intermediate Risk Prostate Cancer

Interventions: Biological: ChAdOx1-MVA 5T4 vaccine
Drug: Nivolumab Infusion [Opdivo]

First Posted Date: 2019-01-24

Last Posted Date: 2020-12-01

Lead Sponsor: University of Oxford

Target Recruit Count: 23

Registration Number: NCT03815942

Locations: 🇬🇧
Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
🇬🇧
Department of Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom

OxPALM: Oxford Study on Probiotics and Low Mood

Not Applicable

Conditions: Cognitive Change
Mood

Interventions: Dietary Supplement: Bio-Kult
Other: Placebo

First Posted Date: 2019-01-11

Last Posted Date: 2019-01-11

Lead Sponsor: University of Oxford

Target Recruit Count: 60

Registration Number: NCT03801655

Locations: 🇬🇧
Warneford Hospital, Oxford, Oxfordshire, United Kingdom

Psoriatic Oligoarthritis Intervention With Symptomatic thErapy

Phase 4

Completed

Conditions: Psoriatic Arthritis

Interventions: Drug: Methotrexate
Drug: Methylprednisolone
Drug: Sulfasalazine
Drug: Triamcinolone
Drug: Leflunomide

First Posted Date: 2019-01-09

Last Posted Date: 2021-05-10

Lead Sponsor: University of Oxford

Target Recruit Count: 1

Registration Number: NCT03797872

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection

Early Phase 1

Conditions: Malaria, Vivax

Interventions: Biological: P. vivax infected inoculum (parasitised red blood cells)

First Posted Date: 2019-01-09

Last Posted Date: 2022-08-17

Lead Sponsor: University of Oxford

Target Recruit Count: 19

Registration Number: NCT03797989

Locations: 🇬🇧
Centre for Clinical Vaccinology & Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)

Phase 2

Conditions: Type1 Diabetes

Interventions: Other: Placebo
Drug: Aldesleukin

First Posted Date: 2018-12-20

Last Posted Date: 2021-12-16

Lead Sponsor: University of Oxford

Target Recruit Count: 41

Registration Number: NCT03782636

Locations: 🇬🇧
Bristol Royal Hospital for Children, Bristol, United Kingdom
🇬🇧
Nottingham Children's Hospital, Nottingham, United Kingdom
🇬🇧
The Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom

and more 2 locations

Neurofeedback for Stroke Rehabilitation

Not Applicable

Terminated

Conditions: Stroke

Interventions: Other: Neurofeedback
Other: Sham Neurofeedback

First Posted Date: 2018-12-14

Last Posted Date: 2023-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 27

Registration Number: NCT03775915

Locations: 🇬🇧
Wellcome Centre for Integrative Neuroimaging (WIN), Oxford, United Kingdom

SyncAV Study: Investigation of the Efficacy of the SyncAV Fusion Pacing Algorithm on Exercise

Not Applicable

Conditions: Heart Failure, Systolic

Interventions: Other: SyncAV algorithm on
Other: SyncAV algorithm off

First Posted Date: 2018-12-07

Last Posted Date: 2020-11-17

Lead Sponsor: University of Oxford

Target Recruit Count: 22

Registration Number: NCT03768804

Locations: 🇬🇧
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy